10-02-2023, 10:07 AM
you're right. The Bci test is primarily used in hormone receptor-positive, early-stage breast cancer, as this subtype is more probable to recur and can profit from extended hormonal cure. Nevertheless, research is ongoing to investigate its utility in more breast cancer subtypes and stages.